FDF Zone at CPhI North America
Did you know manufacturing of finished dosage is expected to grow at an average CAGR of 8.7% by 2020? Furthermore, North America forms a $50 billion formulations market, equating to a 31% market share. Impressive numbers to be sure, and the FDF Finished Drug Products Zone puts you right in the middle of this booming pharma market.
As the landscape continues to evolve with new business models, convergence between drugs and devices, pressure on generics, data intelligence, alternative medicines, single-use systems, and disposables, it can be a challenge to keep up. Not to mention increasing competition, quality compliance, and regulatory scrutiny making it trickier to drive business.
North America forms a $50 billion formulations market, equating to a 31% market share.
Manufacturing of finished dosage is expected to grow at an average CAGR of 8.7% from 2015 to 2020.
Increased demand for generics is expected to continue to rise given its high market penetration.
Increased global demand for affordable prescription and OTC drugs are forcing the industry to manufacture high levels of safe, high quality, and cost effective drugs efficiently.
Network
Connect with thousands of pharma professionals looking to source solutions and meet new partners.
Be Seen As an Industry Leader
Maximise your visibility by showcasing your innovative products to a global engaged audience.
Generate Leads
In only 3 days you will generate high-quality leads for the rest of the year.
Purchasers from around the globe
CPhI North America attracts a regional and international audience with visitors from some of the leading pharmaceutical companies in attendance.
No matter where you are in the pharmaceutical supply chain, CPhI North America’s expo hall has you covered. It’s an expansive marketplace uniting pharma buyers and sellers, strategically positioned in seven unique zones. Having your own stand in a product-specific zone ensures you are in the same hall as your target audience.
